Time-resolved fluorescence immunoassay

• US 4,923,819 A
• Filed: 03/27/1987
• Issued: 05/08/1990
• Est. Priority Date: 03/27/1987
• Status: Expired due to Term

• Current Assignee: Marco Travia
• Original Assignee: Chimerix Incorporated
• Inventors: Guignon, Ernest F., Chao, Yong-Sheng, Wang, Hann-Ping, Fernandez, Salvador M.
• Primary Examiner(s): Kepplinger, Esther M.
• Application Number:
  US07/031,408
• Time in Patent Office: 1,138 Days
• Field of Search: 436/536, 436/546, 436/800, 436/805, 436/518, 436/533, 436/534, 436/505, 436/815, 436/817, 436/818, 436/820
• US Class Current: 436/518
• CPC Class Codes: G01N 21/6408 with measurement of decay time, time resolved fluorescence
• CPC Class Codes: G01N 21/6428 Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" in vivo A61B5/00; immunoassay G01N33/53
• CPC Class Codes: G01N 2201/0697 Pulsed lasers
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: Y10S 435/973 Simultaneous determination of more than one analyte
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/815 Test for named compound or class of compounds
• CPC Class Codes: Y10S 436/818 Human chorionic gonadotropin

Abstract

Fluorescence immunoassay for determining single or multiple analytes based upon a single measurement of fluorescence are described.

Claims

1. A time-resolved fluorescence immunoassay for multiple analytes, comprising the steps of:

a. forming an incubation mixture of;

(i) antibodies against each analyte;

(ii) a predetermined amount of fluorescently labeled analytes wherein each fluorescently labeled analyte has a different fluorescene lifetime; and

(iii) a sample to be tested;

b. incubating the mixture under conditions and for a period of time sufficient for antibody and analytes to complex;

c. determining contemporaneously the amount of each fluorescently labeled analyte bound with antibody as an indication of the amount of each corresponding analyte in the sample, by (i) exciting the fluorescently labeled analyte with a light pulse; and

(ii) determining the amplitude of each fluorescence decay curve for the antibody-bound fluorescently labeled analyte by a single amplitude measurement measuring all of the fluorescence reaching the detector from the instant of excitation.

2. A method of claim 1 wherein the antibodies are immobilized on a solid phase.

3. A method of claim 2 wherein the solid phase is separated from the mixture after incubation in Step (c).

4. A method of claim 1, wherein the amplitude of the fluorescence decay curve for each analyte is determined by:

(a) exciting the antibody-bound fluorescently labeled analyte with a single pulse of light energy to induce fluorescence;

(b) separately detecting in a detector and generating;

(i) an electrical signal corresponding to the fluorescence transient waveform F(t) induced by the single pulse, as distorted by said detector and said pulse, and

(ii) an electrical signal corresponding to the waveform E(t) of said single pulse, as distorted by the impulse response of said detector,

(c) separately displaying an image of the waveforms F(t) and E(t);

(d) digitizing a predetermined number of data points on each such image, as digital numbers representing points on the waveforms;

(e) storing said numbers in memory as data points of T(t) and F(t); and

(f) calculating the true impulse response fluorescence waveform F(t) from the stored data point numbers by convoluting E(t) with a predetermined trial function F(t)_calc having adjustable parameters and comparing the data points of the convoluted F(t)_calc with data points corresponding to F(t) data points, wherein the trial function is the sum of a plural number, ith, of exponential curves A₁ exp(-t/T₂)+A₂ exp(-t/T₂)---A_ith exp(-t/T_ith), where i is the number of analytes, T is the fluorescence lifetime, and the parameter A is proportional to the concentration of each antibody-bound fluorescently labeled analyte.

5. A time-resolved fluorescence immunoassay for multiple analytes, comprising the steps of:

a. providing an immunoadsorbent comprising a solid phase having affixed thereto capture antibodies specific for each analyte to be tested;

b. incubating the immunoadsorbent with a sample to be tested for a period of time and under conditions sufficient for analytes in the sample to complex with the capture antibodies;

c. separating the immunoadsorbent and sample;

d. incubating the immunoadsorbent and a solution containing fluorescently labeled antibodies specific for each analyte, each labeled antibody having a different fluorescence lifetime;

e. separating the immunoadsorbent and the solution;

f. determining contemporaneously the amount of each conjugate associated with the immunoadsorbent as an indication of the amount of each analyte in the sample by (i) exciting the fluorescently labeled antibodies with a light pulse; and

(ii) determining the amplitude of the fluorescence decay curve of each conjugate by measuring all of the fluorescence reaching the detector from the instant of excitation with a single amplitude measurement.

6. An assay of claim 5, wherein the solid phase is a bead, microwell, or test tube.

7. A method of claim 5, wherein, the amplitude is determined by:

(a) exciting the fluorophores associated with the immunoadsorbent with a single pulse of light energy to induce fluorescence;

(b) separately detecting in a detector and generating;

(i) an electrical signal corresponding to the fluorescence transient waveform F(t) induced by said single pulse, as distorted by said detector and said pulse, and

(ii) an electrical signal corresponding to the waveform E(t) of said single pulse, as distorted by the impulse response of said detector,

(c) separately displaying an image of said waveforms F(t) and E(t);

(d) digitizing a predetermined number of data points on each such image, as digital numbers representing points on said waveforms;

(e) storing said numbers in memory as data points of T(t) and F(t); and

(f) calculating the true impulse response fluorescence waveform F(t) from the stored data point numbers by convoluting E(t) with a predetermined trial function F(t)_calc having adjustable parameters and comparing the data points of the convoluted F(t)_calc with data points corresponding to F(t) data points, wherein the trial function is the sum of a plural number, ith, of exponential curves A₁ exp(-t/T₂)+A₂ exp(-t/TH2Y) --- A_ith exp(-t/T_ith), where i is the number of analytes, T is the fluorescence lifetime, and the parameter A is proportional to the concentration of each antibody-bound fluorescently labeled analyte.

8. A time-resolved fluorescence immunoassay for multiple analytes, comprising the steps of:

a. providing an immunoadsorbent comprising a solid phase having affixed thereto capture antibodies specific for each analyte to be tested;

b. incubating the immunoadsorbent with a sample to be tested for a period of time and under conditions sufficient for analytes in the sample to complex with the capture antibodies;

c. separating the immunoadsorbent and the sample;

d. incubating the immunoadsorbent with a solution containing second antibodies against each of the analytes, the incubation being carried out under conditions and for a period of time which permits the second antibodies to complex with analyte bound to the immunoadsorbent wherein each of the second antibodies are antigenically distinct;

e. separating the immunoadsorbent and the solution;

f. incubating the immunoadsorbent and a solution containing fluorescent antibody conjugates against the second antibodies, the conjugates comprising an antibody against each second antibody labeled with a fluorophore, each conjugate having a different fluorescence lifetime;

g. separating the immunoadsorbent and the solution; and

h. determining contemporaneously the amount of each conjugate associated with the immunoadsorbent as an indication of the amount of each corresponding analyte in the sample by (i) exciting the fluorophone with a light pulse; and

(ii) determining the amplitude of the fluorescence decay curve of each fluorophore by measuring all of the fluorescence reaching the detector from the instant of excitation with a single amplitude measurement.

9. A method of claim 8, wherein the solid phase is a bead, microwell or test tube.

10. A method of claim 8, wherein the capture antibodies are monoclonal antibodies, the second antibodies are polyclonal antibodies, and the conjugates comprise fluorescently labeled polyclonal antibodies.

11. A method of claim 8, wherein the conjugates have fluorescent lifetimes which differ from each other by greater than about 20 nanosec.

12. A method of claim 8 wherein the amplitude is determined by:

(a) exciting fluorescently labeled antibody associated with the immunoadsorbent with a single pulse of light energy to induce fluorescence;

(b) separately detecting in a detector and generating;

(i) an electrical signal corresponding to the fluorescence transient waveform F(t) induced by said single pulse, as distorted by said detector and said pulse, and

(ii) an electrical signal corresponding to the waveform E(t) of said single pulse, as distorted by the impulse response of said detector,

(c) separately displaying an image of said waveforms F(t) and E(t);

(d) digitizing a predetermined number of data points on each such image, as digital numbers representing points on said waveforms;

(e) storing said numbers in memory as data points of T(t) and F(t); and

(f) calculating the true impulse response fluorescence waveform F(t) from the stored data point numbers by convoluting E(t) with a predetermined trial function F(t)_calc having adjustable parameters and comparing the data points of the convoluted F(t)_calc with data points corresponding to F(t) data points, wherein the trail function is the sum of a plural number, ith, of exponential curves A₁ exp(-t/Tphd

     2)+A₂ exp(-t/TH2Y) ---A_ith exp(-t/T_ith), where i is the number of analytes, T is the fluorescence lifetime, and the parameter A is proportional to the concentration of each antibody-bound fluorescently labeled analyte.